Search Results 21-30 of 17377 for GLP-1 secretion
2025 Jan 1; 328 (1): ... The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. ... GLP-1 agonists reduce ...
In response to chemical and mechanical stimuli, these cells secrete a variety of important hormones, such as GLP-1 and GLP-2, PYY, CCK and serotonin. The ...
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight ...
... GLP-1 agonist in the post-Acute Heart Failure Syndrome (AHFS) discharge period will be associated with greater clinical stability at six months as assessed ...
Both RYGB and SG increase GLP-1 concentrations which directly affect B-cell function. ... GLP-1 is less marked. ... discharge, prevent decompensation, and prevent ...
The purpose of this study is to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.
The purpose of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1 ...
The purpose of this study is to evaluate the effect of tradipitant relative to placebo on proportion of subjects with at least 1 vomiting episode per week ...
The first, glucagon-like peptide 1 (GLP-1), a gastrointestinal hormone, stimulates the pancreas to make more beta cells, which increases the amount of insulin ...
Using combined therapy to treat obesity, combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Learn more.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.